197 related articles for article (PubMed ID: 35143958)
1. Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer.
Wan Q; Zeng Z; Qi J; Chen Z; Liu X; Zu Y
Mol Ther; 2022 Jun; 30(6):2242-2256. PubMed ID: 35143958
[TBL] [Abstract][Full Text] [Related]
2. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
Duan T; Xu Z; Sun F; Wang Y; Zhang J; Luo C; Wang M
Biomed Pharmacother; 2019 Sep; 117():109121. PubMed ID: 31252265
[TBL] [Abstract][Full Text] [Related]
3. Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy.
Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Karthikkumar V; Wang MH
Int J Biol Macromol; 2022 Jan; 195():22-29. PubMed ID: 34861273
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy.
Zhao N; Zeng Z; Zu Y
Small; 2018 Jan; 14(4):. PubMed ID: 29205808
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
Yao F; An Y; Li X; Li Z; Duan J; Yang XD
Int J Nanomedicine; 2020; 15():2119-2129. PubMed ID: 32280210
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Delivery of Polymeric Tadpole Nanostructures with High Selectivity to Triple Negative Breast Cancer Cells.
Bobrin VA; Lin Y; He J; Qi Y; Gu W; Monteiro MJ
Biomacromolecules; 2020 Nov; 21(11):4457-4468. PubMed ID: 32212644
[TBL] [Abstract][Full Text] [Related]
7. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
Valcourt DM; Dang MN; Scully MA; Day ES
ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466
[TBL] [Abstract][Full Text] [Related]
9. Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine.
Yao F; An Y; Lai X; Li X; Yu Z; Yang XD
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7515-7527. PubMed ID: 36966395
[TBL] [Abstract][Full Text] [Related]
10. Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy.
Zeng Z; Qi J; Wan Q; Zu Y
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452182
[TBL] [Abstract][Full Text] [Related]
11. The application of aptamer 5TR1 in triple negative breast cancer target therapy.
Luo S; Wang S; Luo N; Chen F; Hu C; Zhang K
J Cell Biochem; 2018 Jan; 119(1):896-908. PubMed ID: 28671278
[TBL] [Abstract][Full Text] [Related]
12. Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors.
Agnello L; Tortorella S; d'Argenio A; Carbone C; Camorani S; Locatelli E; Auletta L; Sorrentino D; Fedele M; Zannetti A; Franchini MC; Cerchia L
J Exp Clin Cancer Res; 2021 Jul; 40(1):239. PubMed ID: 34294133
[TBL] [Abstract][Full Text] [Related]
13. An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells.
Zhao N; You J; Zeng Z; Li C; Zu Y
Small; 2013 Oct; 9(20):3477-84. PubMed ID: 23609964
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.
Jiao J; Zou Q; Zou MH; Guo RM; Zhu S; Zhang Y
Neoplasma; 2016; 63(4):569-75. PubMed ID: 27268920
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
18. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
